{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:30:05Z","timestamp":1791379805840,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.chest.2023.06.024","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T10:14:37Z","timestamp":1687601677000},"page":"1444-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19"],"prefix":"10.1016","volume":"164","author":[{"given":"Amy L.","family":"Lightner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Ransom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy I.","family":"Melson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Awili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2023.06.024_bib1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian","year":"2020","journal-title":"Modern Pathol"},{"issue":"4","key":"10.1016\/j.chest.2023.06.024_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.chest.2023.06.024_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis","volume":"14","author":"Hasan","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2023.06.024_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.chest.2023.06.024_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcyt.2022.10.003","article-title":"Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?","volume":"25","author":"Kirkham","year":"2023","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.chest.2023.06.024_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.chest.2023.06.024_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2014.00608","article-title":"Extracellular vesicles: potential roles in regenerative medicine","volume":"5","author":"De Jong","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-021-02143-w","article-title":"MSC-NTF (NurOwn\u00ae) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model","volume":"12","author":"Kaspi","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.chest.2023.06.024_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s13770-022-00441-9","article-title":"Mesenchymal stem cell-derived extracellular vesicles in the management of COVID19-associated lung injury: a review on publications, clinical trials and patent landscape","volume":"19","author":"Krishnan","year":"2022","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","article-title":"Advances in mesenchymal stem cell exosomes: a review","volume":"12","author":"Tang","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"10.1016\/j.chest.2023.06.024_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Develop"},{"issue":"14","key":"10.1016\/j.chest.2023.06.024_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/scd.2020.0095","article-title":"Response to Lim et\u00a0al. re: \"Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.\"","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Develop"},{"issue":"8","key":"10.1016\/j.chest.2023.06.024_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2023.06.024_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0885066621994476","article-title":"Clinical course and outcome of COVID-19 acute respiratory distress syndrome: data from a national repository","volume":"36","author":"El-Solh","year":"2021","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.chest.2023.06.024_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114800","article-title":"Remdesivir: quo vadis?","volume":"193","author":"De Clercq","year":"2021","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00726-4","article-title":"Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis","volume":"11","author":"Malgie","year":"2021","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.chest.2023.06.024_bib20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2023.06.024_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2201662","article-title":"Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19","volume":"387","author":"Bramante","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.chest.2023.06.024_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10285","key":"10.1016\/j.chest.2023.06.024_bib23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Group","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial","volume":"329","author":"Higgins","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2023.06.024_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"10.1016\/j.chest.2023.06.024_bib26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa2115869","article-title":"Effect of early treatment with ivermectin among patients with Covid-19","volume":"386","author":"Reis","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2023.06.024_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.chest.2023.06.024_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs\u00a0standard care on clinical status at 11\u00a0days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"issue":"10236","key":"10.1016\/j.chest.2023.06.024_bib29","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.chest.2023.06.024_bib30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/22221751.2022.2059405","article-title":"Clinical\u00a0efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a\u00a0systematic review and meta-analysis","volume":"11","author":"Yu","year":"2022","journal-title":"Emerg Microbes Infect"}],"updated-by":[{"DOI":"10.1016\/j.chest.2024.05.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223009261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223009261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T01:16:01Z","timestamp":1719450961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223009261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0012369223009261"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.06.024","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}